Living with hepatitis C.

Autor: Gallagher GB (AUTHOR)

Publikováno v: Better Nutrition. Jun2006, Vol. 68 Issue 6, p44-46. 2p.

Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I-IIIA breast cancer.

Autor: Bhimani J; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., O'Connell K; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Persaud S; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Blinder V; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Burganowski R; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington, USA., Ergas IJ; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA., Foley MJ; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA., Gallagher GB; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Griggs JJ; Department of Medicine, Division of Hematology/Oncology and Department of Health Management and Policy, University of Michigan, Ann Arbor, Michigan, USA., Heon N; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Kolevska T; Department of Oncology, Kaiser Permanente Medical Center, Vallejo, California, USA., Kotsurovskyy Y; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Kroenke CH; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.; Kaiser Permanente School of Medicine, Pasadena, California, USA., Laurent CA; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA., Liu R; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.; San Francisco Medical Center, Kaiser Permanente Northern California, San Francisco, California, USA., Nakata KG; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington, USA., Rivera DR; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland, USA., Roh JM; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA., Tabatabai S; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Valice E; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA., Bandera EV; Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Bowles EJA; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington, USA., Kushi LH; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA., Kantor ED; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Publikováno v: International journal of cancer [Int J Cancer] 2024 Nov 01; Vol. 155 (9), pp. 1577-1592. Date of Electronic Publication: 2024 Jul 06.

Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer.

Autor: Bhimani J; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., O'Connell K; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Persaud S; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Blinder V; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Burganowski-Doud RP; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington., Ergas IJ; Division of Research, Kaiser Permanente Northern California, Oakland, California., Gallagher GB; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Griggs JJ; Division of Hematology/Oncology, Department of Medicine, University of Michigan, Ann Arbor, Michigan.; Department of Health Management and Policy, University of Michigan, Ann Arbor, Michigan., Heon N; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Kolevska T; Department of Oncology, Kaiser Permanente Medical Center, Vallejo, California., Kotsurovskyy Y; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Kroenke CH; Division of Research, Kaiser Permanente Northern California, Oakland, California.; Kaiser Permanente School of Medicine, Pasadena, California., Laurent CA; Division of Research, Kaiser Permanente Northern California, Oakland, California., Liu R; Division of Research, Kaiser Permanente Northern California, Oakland, California.; San Francisco Medical Center, Kaiser Permanente Northern California, San Francisco, California., Nakata KG; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington., Rivera DR; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland., Roh JM; Division of Research, Kaiser Permanente Northern California, Oakland, California., Tabatabai S; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Valice E; Division of Research, Kaiser Permanente Northern California, Oakland, California., Bandera EV; Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey., Aiello Bowles EJ; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington., Kushi LH; Division of Research, Kaiser Permanente Northern California, Oakland, California., Kantor ED; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.

Publikováno v: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2024 Oct 02; Vol. 33 (10), pp. 1286-1297.

Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast Cancer.

Autor: Bhimani J; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., O'Connell K; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Ergas IJ; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Foley M; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Gallagher GB; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Griggs JJ; Department of Medicine, Division of Hematology/Oncology and Department of Health Management and Policy, University of Michigan, Ann Arbor, MI., Heon N; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Kolevska T; Department of Oncology, Kaiser Permanente Medical Center, Vallejo, CA., Kotsurovskyy Y; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Kroenke CH; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Laurent CA; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Liu R; Division of Research, Kaiser Permanente Northern California, Oakland, CA.; San Francisco Medical Center, Kaiser Permanente Northern California, San Francisco, CA., Nakata KG; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, WA., Persaud S; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Rivera DR; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD., Roh JM; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Tabatabai S; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Valice E; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Bowles EJA; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, WA., Bandera EV; Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Kushi LH; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Kantor ED; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.

Publikováno v: JCO clinical cancer informatics [JCO Clin Cancer Inform] 2024 Apr; Vol. 8, pp. e2300209.